Assignee
COUNTERPOINT BIOMEDICA LLC
US·4 granted patents·3 pending applications·3 citations·filing 2015–2025
Top patents by PatentIndex Score
7 records- 0180US11273206B2Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptidesCOUNTERPOINT BIOMEDICA LLC·Filed 2019·Granted Mar 15, 2022·1 cites·18 claims
- 0279US10981980B2Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cellsCOUNTERPOINT BIOMEDICA LLC·Filed 2017·Granted Apr 20, 2021·1 cites·10 claims
- 0377US10913779B2Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infectionsCOUNTERPOINT BIOMEDICA LLC·Filed 2018·Granted Feb 9, 2021·1 cites·21 claims
- 0467US2022041696A1Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cellsCOUNTERPOINT BIOMEDICA LLC·Filed 2021·Application pending·0 cites
- 0561US10420820B2Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptidesCOUNTERPOINT BIOMEDICA LLC·Filed 2015·Granted Sep 24, 2019·0 cites·20 claims
- 0661US2022017586A1Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infectionsCOUNTERPOINT BIOMEDICA LLC·Filed 2021·Application pending·0 cites
- 0760US2026053875A1Transdermal drug-carrier vehicle for topical, lymphatic, muscular, and systemic delivery of bioactive andrographolides, and/or epigallocatechin gallateCOUNTERPOINT BIOMEDICA LLC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when COUNTERPOINT BIOMEDICA LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →